|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 55.92 USD | -0.57% |
|
54.50 | -2.55% |
| 06-15 | China's Harbour BioMed to focus on another patent case after $20 million damages award | RE |
| 06-11 | Takeda's AI-crafted psoriasis pill tops Bristol Myers' Sotyktu in head-to-head trial | RE |
| Market Cap | 114B 98.41B 90.62B 85.08B 160B 10,796B 161B 1,071B 417B 5,287B 429B 419B 18,322B | P/E Ratio 2026 * |
11x | P/E Ratio 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 143B 123B 113B 106B 200B 13,497B 202B 1,339B 522B 6,609B 536B 524B 22,905B | EV / Sales 2026 * |
3.02x | EV / Sales 2027 * | 2.95x |
| Free-Float |
69.8% | Yield 2026 * |
4.5% | Yield 2027 * | 4.62% |
Last Transcript: Bristol-Myers Squibb Company
| 1 day | -0.57% | ||
| 1 week | -0.99% | ||
| Current month | -2.20% | ||
| 1 month | -1.89% | ||
| 3 months | -6.35% | ||
| 6 months | +3.12% | ||
| Current year | +3.67% |
| 1 week | 55.44 |  | 57.6 |
| 1 month | 54.2 | | 60.25 |
| Current year | 52.06 | | 62.89 |
| 1 year | 42.52 | | 62.89 |
| 3 years | 39.35 | | 66.38 |
| 5 years | 39.35 | | 81.44 |
| 10 years | 39.35 | | 81.44 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 2023-10-31 | |
David Elkins
DFI | Director of Finance/CFO | 58 | 2019-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | 53 | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 55 | 2024-03-31 | |
Peter Arduini
BRD | Director/Board Member | 61 | 2016-03-31 |
Theodore Samuels
BRD | Director/Board Member | 71 | 2017-02-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Fiscal year | EVP, Corporate Affairs | 19,956 | 0.0010% | ||
| 04-30 | Fiscal year | Executive/Senior Manager | 3,548 | 0.0002% | ||
| 03-31 | Fiscal year | Chief Operating Officer | 8,306 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.57% | -0.99% | +14.92% | -15.48% | 114B | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,001B | |
| -0.20% | -0.77% | +51.51% | +43.20% | 566B | |
| +0.40% | -1.31% | +16.56% | +60.47% | 393B | |
| -0.08% | +2.29% | +24.04% | +16.53% | 326B | |
| +0.11% | +0.47% | +25.14% | +31.65% | 276B | |
| +0.49% | -0.82% | +25.25% | +14.67% | 277B | |
| +1.77% | +0.71% | -41.58% | -47.34% | 193B | |
| -0.77% | +0.95% | +17.69% | +51.46% | 188B | |
| +2.36% | +1.38% | +14.80% | +61.34% | 158B | |
| Average | +0.28% | +0.45% | +18.73% | +36.72% | 349.1B | |
| Weighted average by Cap. | +0.01% | -0.27% | +27.44% | +64.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.31B 40.77B 37.54B 35.25B 66.18B 4,473B 66.88B 444B 173B 2,190B 178B 174B 7,591B | 46.22B 39.83B 36.68B 34.44B 64.66B 4,370B 65.34B 433B 169B 2,140B 173B 170B 7,416B |
| Net income | 10.55B 9.1B 8.38B 7.86B 14.77B 998B 14.92B 98.98B 38.56B 489B 39.61B 38.77B 1,694B | 10.26B 8.84B 8.14B 7.64B 14.35B 970B 14.5B 96.21B 37.48B 475B 38.5B 37.69B 1,646B |
| Net Debt | 28.56B 24.62B 22.67B 21.28B 39.96B 2,700B 40.38B 268B 104B 1,322B 107B 105B 4,583B | 22.03B 18.99B 17.49B 16.42B 30.83B 2,083B 31.15B 207B 80.5B 1,020B 82.69B 80.94B 3,535B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 55.92 $ | -0.57% | 11,945,740 |
| 26-06-15 | 56.24 $ | -1.56% | 13,561,210 |
| 26-06-12 | 57.13 $ | +0.40% | 7,840,637 |
| 26-06-11 | 56.90 $ | +2.34% | 8,900,748 |
| 26-06-10 | 55.60 $ | -1.56% | 8,146,820 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMY Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition